This inventor holds 3 USPTO granted patents. Top assignees: Antibioticos, S.a., Antibiotics, S.a.. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2001
Title: Miguel Angel Moreno Valle: Innovator in Biochemical Production
Introduction
Miguel Angel Moreno Valle is a notable inventor based in Leon, Spain. He has made significant contributions to the field of biochemistry, particularly in the production of antibiotics and enzymes. With a total of 3 patents, his work has had a considerable impact on the pharmaceutical industry.
Latest Patents
Among his latest patents is a process for increasing the production of penicillin G (benzylpenicillin) in Penicillium chrysogenum by the expression of the PCL gene. This innovative method involves isolating DNA that encodes phenyl acetyl-CoA-ligase and transforming the strain to enhance penicillin G production. Additionally, he has developed a process for producing the enzyme D-amino acid oxidase from Rhodotorula gracilis in host cells. This process includes isolating complementary DNA corresponding to the messenger RNA of the gene coding for D-amino acid oxidase, fusing it with a high-efficiency promoter sequence, and cultivating the transformed host cells to collect the enzyme.
Career Highlights
Throughout his career, Miguel has worked with prominent companies such as Antibioticos, S.A. and Antibiotics, S.A. His expertise in biochemical processes has been instrumental in advancing antibiotic production techniques.
Collaborations
Miguel has collaborated with notable individuals in his field, including Jose Luis Barredo Fuente and Bruno Diez Garcia. These partnerships have contributed to the success of his innovative projects.
Conclusion
Miguel Angel Moreno Valle is a distinguished inventor whose work in biochemistry has led to significant advancements in antibiotic and enzyme production. His patents reflect his commitment to innovation and the betterment of pharmaceutical processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile